Outcomes of Related Donor HLA-Identical or HLA-Haploidentical Allogeneic Blood or Marrow Transplantation for Peripheral T Cell Lymphoma
Jennifer A. Kanakry(National Institutes of Health), Richard F. Ambinder(Johns Hopkins University), Heather J. Symons(Johns Hopkins University), Leo Luznik(Sidney Kimmel Comprehensive Cancer Center), Christopher D. Gocke, Richard J. Jones(Sidney Kimmel Cancer Center), Yvette L. Kasamon(Johns Hopkins University), Ephraim J. Fuchs(Johns Hopkins Hospital), Nilanjan Ghosh(Levine Cancer Institute), Janice Davis‐Sproul(Johns Hopkins University), Hua-Ling Tsai(Johns Hopkins University), Douglas E. Gladstone(Northwell Health), Lode J. Swinnen(Johns Hopkins University), Javier Bolaños‐Meade(Johns Hopkins University)
Cited by 88
Related Papers
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
B Cells Turn Off Virgin But Not Memory T Cells
|Science|1992|570
Hodgkin lymphoma: A review and update on recent progress
|CA A Cancer Journal for Clinicians|2017|479